“Upon examination, we came to know that she is a known case of type-2 diabetes for the past 15 years. The patient has been on medication, but her blood sugar levels were not well-controlle ...

Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

Sean M. Oser “If these kinds of glucose levels can be achieved with less intensive engagement required by the treating practitioner and less work by the patient, imagine how many more patients ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Chronic diseases require a lifetime of long-term follow-up. Randomised controlled trials are considered the most robust ...

CagriSema-treated patients achieved superior weight loss compared with those who received placebo. Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide 2.4mg and ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal ...

Diabetes can affect how the body manages temperature and may cause some people to sweat more or less. This can include night sweats, sweating while eating, or sweating when it’s cool. Treatment ...